142 related articles for article (PubMed ID: 31945121)
21. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
[TBL] [Abstract][Full Text] [Related]
22. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.
Polewicz M; Gracia A; Garlapati S; van Kessel J; Strom S; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
Vaccine; 2013 Jun; 31(31):3148-55. PubMed ID: 23684829
[TBL] [Abstract][Full Text] [Related]
23. Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier.
Alonso S; Willery E; Renauld-Mongénie G; Locht C
Infect Immun; 2005 Jul; 73(7):4295-301. PubMed ID: 15972522
[TBL] [Abstract][Full Text] [Related]
24.
Yount KS; Jennings-Gee J; Caution K; Fullen AR; Corps KN; Quataert S; Deora R; Dubey P
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308083
[No Abstract] [Full Text] [Related]
25. Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice.
Piao Z; Akeda Y; Takeuchi D; Ishii KJ; Ubukata K; Briles DE; Tomono K; Oishi K
Vaccine; 2014 Sep; 32(43):5607-13. PubMed ID: 25132335
[TBL] [Abstract][Full Text] [Related]
26. Liposome-based dry powder vaccine immunization targeting the lungs induces broad protection against pneumococcus.
Rodrigues TC; Figueiredo DB; Gonçalves VM; Kaneko K; Saleem IY; Miyaji EN
J Control Release; 2024 Apr; 368():184-198. PubMed ID: 38395155
[TBL] [Abstract][Full Text] [Related]
27. Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments.
Lu J; Guo J; Wang D; Yu J; Gu T; Jiang C; Kong W; Wu Y
Hum Vaccin Immunother; 2019; 15(2):371-380. PubMed ID: 30235046
[TBL] [Abstract][Full Text] [Related]
28. Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.
Moreno AT; Oliveira ML; Ferreira DM; Ho PL; Darrieux M; Leite LC; Ferreira JM; Pimenta FC; Andrade AL; Miyaji EN
Clin Vaccine Immunol; 2010 Mar; 17(3):439-46. PubMed ID: 20089795
[TBL] [Abstract][Full Text] [Related]
29. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
30. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
Conway MA; Madrigal-Estebas L; McClean S; Brayden DJ; Mills KH
Vaccine; 2001 Feb; 19(15-16):1940-50. PubMed ID: 11228364
[TBL] [Abstract][Full Text] [Related]
31. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
Goulart C; Rodriguez D; Kanno AI; Converso TR; Lu YJ; Malley R; Leite LCC
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768668
[TBL] [Abstract][Full Text] [Related]
32. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
33. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
[TBL] [Abstract][Full Text] [Related]
34. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
Munoz JJ; Peacock MG
Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte-macrophage colony-stimulating factor DNA prime-protein boost strategy to enhance efficacy of a recombinant pertussis DNA vaccine.
Li QT; Zhu YZ; Chu JY; Dong K; He P; Feng CY; Hu BY; Zhang SM; Guo XK
Acta Pharmacol Sin; 2006 Nov; 27(11):1487-94. PubMed ID: 17049126
[TBL] [Abstract][Full Text] [Related]
36. Maternal immunization with pneumococcal surface protein A provides the immune memories of offspring against pneumococcal infection.
Kono M; Iyo T; Murakami D; Sakatani H; Nanushaj D; Hotomi M
Front Cell Infect Microbiol; 2023; 13():1059603. PubMed ID: 37033488
[TBL] [Abstract][Full Text] [Related]
37. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
38. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
[TBL] [Abstract][Full Text] [Related]
39. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
Sato H; Sato Y
Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
[TBL] [Abstract][Full Text] [Related]
40. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
